It is therefore interesting, and potentially functionally-relevant, to speculate that the regulation of amylin levels could be a critical molecular connection between diverse forms of neurodegenerative diseases that also possess a metabolic deficit (Martin et al., 2008; Cai et al., 2012). This evidence concerns the gene IAPP and neurodegenerative disease.